154 related articles for article (PubMed ID: 37750427)
1. Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
Elliott RA; Rogers G; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Sutton CJ; Taxiarchi VP; Burns M; Thabit H; Wilmot EG; Leelarathna L;
Diabet Med; 2024 Mar; 41(3):e15232. PubMed ID: 37750427
[TBL] [Abstract][Full Text] [Related]
2. Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9).
Emamipour S; van Dijk PR; Bilo HJG; Edens MA; van der Galiën O; Postma MJ; Feenstra TL; van Boven JFM
J Diabetes Sci Technol; 2024 Jan; 18(1):135-142. PubMed ID: 35815617
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
[No Abstract] [Full Text] [Related]
5. Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
Leelarathna L; Sutton CJ; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Krishan A; Taxiarchi VP; Barnard-Kelly K; Elliott RA; Burns M; Camm M; Thabit H; Wilmot EG;
Diabet Med; 2024 Mar; 41(3):e15249. PubMed ID: 37897112
[TBL] [Abstract][Full Text] [Related]
6. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
Rotondi MA; Wong O; Riddell M; Perkins B
Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
[TBL] [Abstract][Full Text] [Related]
8. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece.
Lambadiari V; Ozdemir Saltik AZ; de Portu S; Buompensiere MI; Kountouri A; Korakas E; Sharland H; Cohen O
Diabetes Technol Ther; 2022 May; 24(5):316-323. PubMed ID: 34962140
[No Abstract] [Full Text] [Related]
10. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.
Alshannaq H; Cogswell G; Pollock RF; Ahmed W; Norman GJ; Lynch PM; Roze S
Diabetes Obes Metab; 2023 Sep; 25(9):2704-2713. PubMed ID: 37334522
[TBL] [Abstract][Full Text] [Related]
12. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
[TBL] [Abstract][Full Text] [Related]
13. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
[TBL] [Abstract][Full Text] [Related]
14. Long-term health economic evaluation of intermittently scanned glucose monitoring compared with self-monitoring blood glucose in a real-world setting in Finnish adult individuals with type 1 diabetes.
Mustonen J; Rautiainen PA; Lamidi ML; Lavikainen P; Martikainen J; Laatikainen T
Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38842899
[TBL] [Abstract][Full Text] [Related]
15. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
[TBL] [Abstract][Full Text] [Related]
16. Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.
Reddy M; Oliver N
Diabetes Technol Ther; 2020 Mar; 22(3):235-238. PubMed ID: 31833786
[TBL] [Abstract][Full Text] [Related]
17. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhou Y; Sardana D; Kuroko S; Haszard JJ; de Block MI; Weng J; Jefferies C; Wheeler BJ
Diabet Med; 2024 Mar; 41(3):e15280. PubMed ID: 38197238
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
Chaugule S; Graham C
J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
[TBL] [Abstract][Full Text] [Related]
19. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
